“Regular use of a large-gauge catheter is counter intuitive when placed in the small veins of the hand with extension tubing. More research is needed to promote best practice around gauge selection, site and women’s experience” Kearney et al (2021).
“The placement of a totally implantable venous-access device (TIVAD) could be an alternative to overcome these difficulties in certain subjects” Macau et al (2021).
“We experienced complete failure of a needle-free connector extension set with a Luer-access split septum device in multiple patients due to the split septum remaining fused and essentially unsplit despite being connected on both ends” Naftalovich et al (2021).
“The novel objective of our study was to determine the capability of insertion skin site culture to predict CRBSI and primary bloodstream infection (PBSI), that include CRBSI and bloodstream infection of unknown origin (BSIUO)” Lorente et al (2021).
“We will synthesise the evidence concerning safe and effective preparation and administration of intravenous therapy and medicines to inform the development of a national guideline for healthcare professionals in Ireland” Carr et al (2021).
“High-quality care was more effective than routine care in reducing the incidence and degree of infiltration and extravasation of peripheral intravenous infusions” Litao et al (2021).
“Implementing automated BC in a resource-limited setting is possible and improves microbiological diagnostic performance” von Laer et al (2021).
“In this study, biologic infusions administered at home, compared with those administered at a facility, were associated with increased adverse events requiring escalation of care” Baker et al (2021).
“We found that these catheter hubs were compatible, fully operational, and airtight with use of 3M Curos stopper caps after 6 months of use with 122 caps per catheter hub” Simon et al (2021).